Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-01-22

FDA Approved: FINGOLIMOD — Supplemental Application (Apotex Corp.)

View source ↗

Summary

FDA approves a supplemental application for fingolimod by Apotex Corp., enabling the manufacture and distribution of a generic fingolimod product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fingolimod (fingolimod)

Snippet

SUPPL AP for FINGOLIMOD (FINGOLIMOD)